Agilon Health Inc (NYSE:AGL) Has Recovered 31.82% So Far, But Another -251.36% Loss Is Possible.

Agilon Health Inc (NYSE:AGL)’s traded shares stood at 13.85 million during the last session, with the company’s beta value hitting 0.21. At the close of trading, the stock’s price was $2.20, to imply a decrease of -6.38% or -$0.15 in intraday trading. The AGL share’s 52-week high remains $7.73, putting it -251.36% down since that peak but still an impressive 31.82% since price per share fell to its 52-week low of $1.50.

Analysts have given a consensus recommendation of Buy for Agilon Health Inc (AGL), translating to a mean rating of 2.80. Of 10 analyst(s) looking at the stock, 0 analyst(s) give AGL a Sell rating. 0 of those analysts rate the stock as Overweight while 3 advise Hold as 7 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.09.

Agilon Health Inc (NYSE:AGL) trade information

After registering a -6.38% downside in the last session, Agilon Health Inc (AGL) has traded red over the past five days. The 5-day price performance for the stock is -13.73%, and -43.88% over 30 days. With these gigs, the year-to-date price performance is 15.79%.

The extremes give us $2.5 and $6.5 for target low and target high price respectively. As such, AGL has been trading -195.45% off suggested target high and -13.64% from its likely low.

Agilon Health Inc (AGL) estimates and forecasts

The rating firms project that company’s revenue will shrink -1.71% compared to the previous financial year.

Revenue forecast for the current quarter as set by 16 analysts is 1.47B. Meanwhile, for the current quarter, a total of 16 analyst(s) estimate revenue growth to 1.46B.Earnings reports from the last fiscal year show that sales brought in 1.48B and 1.45B respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -0.68% before jumping 0.89% in the following quarter.

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 3.29% for the past 5-year period. While 2025 is set for a 45.46% return in earnings, projections for the next 5 years are at 41.90% annually.

AGL Dividends

Agilon Health Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

The next major institution holding the largest number of shares is FMR LLC with 56.93 million shares, or about 13.8418% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $372.3 million.

We also have VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and SMALLCAP WORLD FUND INC as the top two Mutual Funds with the largest holdings of the Agilon Health Inc (AGL) shares. Going by data provided on Jan 31, 2025 , VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund holds roughly 33.09 shares. This is just over 7.99% of the total shares, with a market valuation of $72.79 million. Data from the same date shows that the other fund manager holds a little less at 30.86, or 7.46% of the shares, all valued at about 67.9 million.